What is the Role of Antimicrobial Stewardship in Improving Outcomes of Patients with CAP?

Veronique Nussenblatt; Edina Avdic; Sara Cosgrove

doi:10.1016/j.idc.2012.11.008

What is the Role of Antimicrobial Stewardship in Improving Outcomes of Patients with CAP?

Veronique Nussenblatt, Edina Avdic, Sara Cosgrove

School of Medicine

Research output: Contribution to journal › Review article › peer-review

12 Scopus citations

Abstract

Community-acquired pneumonia (CAP) is one of the most common infectious diagnoses encountered in clinical practice and one of the leading causes of death in the United States. Adherence to antibiotic treatment guidelines is inconsistent and the erroneous diagnosis of CAP and misuse of antibiotics is prevalent in both inpatients and outpatients. This review summarizes interventions that may be promoted by antimicrobial stewardship programs to improve outcomes for patients with CAP.

Original language	English (US)
Pages (from-to)	211-228
Number of pages	18
Journal	Infectious disease clinics of North America
Volume	27
Issue number	1
DOIs	https://doi.org/10.1016/j.idc.2012.11.008
State	Published - Mar 2013

Keywords

Antimicrobial stewardship
CAP
Community-acquired pneumonia
Outcomes

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.idc.2012.11.008

Cite this

@article{1442a4463eab41029715675171e15825,

title = "What is the Role of Antimicrobial Stewardship in Improving Outcomes of Patients with CAP?",

abstract = "Community-acquired pneumonia (CAP) is one of the most common infectious diagnoses encountered in clinical practice and one of the leading causes of death in the United States. Adherence to antibiotic treatment guidelines is inconsistent and the erroneous diagnosis of CAP and misuse of antibiotics is prevalent in both inpatients and outpatients. This review summarizes interventions that may be promoted by antimicrobial stewardship programs to improve outcomes for patients with CAP.",

keywords = "Antimicrobial stewardship, CAP, Community-acquired pneumonia, Outcomes",

author = "Veronique Nussenblatt and Edina Avdic and Sara Cosgrove",

note = "Funding Information: Disclosures: In the last two years, Dr Cosgrove has been a consultant for Merck, Novartis, Cerexa, and Ribx. She has received grants from Cubist and AdvanDx . Drs Nussenblatt and Avdic have no disclosures. Copyright: Copyright 2013 Elsevier B.V., All rights reserved.",

year = "2013",

month = mar,

doi = "10.1016/j.idc.2012.11.008",

language = "English (US)",

volume = "27",

pages = "211--228",

journal = "Infectious Disease Clinics of North America",

issn = "0891-5520",